Jacobson Pharma Corporation Limited (HK:2633) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Jacobson Pharma Corporation Limited reported a robust financial performance for the six months ending September 2024, with a 13.3% increase in revenue to HK$810.0 million and a 44.2% surge in profit from continuing operations to HK$140.3 million. The company also declared a 40% higher interim dividend, reflecting strong growth compared to the same period in 2023. These results highlight the company’s resilient business model and its promising outlook for investors.
For further insights into HK:2633 stock, check out TipRanks’ Stock Analysis page.